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An unusual case of an acute hemolytic 
transfusion reaction caused by an autoanti-I
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In general, naturally occurring cold autoagglutinins react 
optimally at low temperatures. We describe a young child who 
experienced an acute hemolytic transfusion reaction by an 
unusual autoanti-I. The IgM autoanti-I was detected at 4°C (titer 
256) and also reacted at 30°C. This case highlights the potential 
hazard of transfusing units of blood immediately upon removal 
from the blood refrigerator, especially into neonates and children 
of small stature. Immunohematology 2011;27:101–103.
Key Words: autoanti-I, acute hemolytic transfusion reaction, 
cold autoagglutinins
In general, naturally occurring cold autoagglutinins react 
optimally at low temperatures (at or below 4°C) with a titer 
below 64, and with low thermal amplitude (maximal thermal 
range at 20°C or less).1 Most cold autoagglutinins are benign, 
usually IgM antibodies, and can be detected by direct saline 
agglutination tests. Clinically significant cold autoagglutinins 
usually react at a thermal amplitude of 30°C or above and may 
activate complement.
Autoanti-I is commonly found to be the specificity 
implicated in cold hemagglutinin disease (CHD), and also 
after mycoplasma infection. In CHD, the cold agglutinin titer 
is usually higher than 1000 when tested at 4°C.2
We report an acute hemolytic transfusion reaction 
(AHTR) in a child of small stature caused by the transfusion 
of two units of blood immediately upon removal from a 
temperature-controlled blood refrigerator, with no warming of 
the units to ambient room temperature. Extensive laboratory 
investigations revealed that the antibody implicated was an 
unusual autoanti-I reacting at 30°C.
This case highlights the potential hazard of transfusing 
cold units of blood taken from a temperature-controlled 
refrigerator to neonates and children of small stature.
Case Report
A 9-year-old boy, with acute lymphoblastic leukemia (ALL), 
was admitted to a district hospital with febrile neutropenia. He 
received intravenous (IV) antibiotics and his fever improved, 
but no organism was identified. His hemoglobin (Hb) fell to 
7.3 g/dL (normal range, 12.2–14.2 g/dL), with a hematocrit 
of 19.5%, and transfusion was requested. The patient’s blood 
group was group A, D+, with no atypical alloantibodies 
detected in the plasma. The direct antiglobulin test (DAT) was 
positive (2+ with anti-C3d only). Two units of crossmatched 
compatible (by indirect antiglobulin technique [IAT] at 37°C) 
group A, D+, K– red blood cells (RBCs) were issued.
The first unit was taken from the temperature-controlled 
blood refrigerator and was immediately transfused without any 
adverse reactions. The second unit was also transfused without 
waiting for the unit to reach ambient room temperature. While 
receiving the second unit, the patient had classic signs of an 
AHTR: high fever of 40°C, rigors, loin pain, sweating, and 
tachycardia. The transfusion was stopped immediately (about 
100 mL had been infused), and IV normal saline, hydrocortisone, 
and chlorpheniramine were given with oral acetaminophen. 
The patient also passed a quantity of dark urine soon after 
cessation of the transfusion, and the left kidney was tender on 
palpation. There was a rise in bilirubin level from 25 μmol/L to 
93 μmol/L (normal, 2–17 μmol/L). The blood film showed some 
RBC agglutination and some atypical lymphocytes.
In view of the severe nature of the reaction and 
hemoglobinuria, the patient was urgently transferred to the 
teaching hospital the same day. The patient remained on IV 
fluid and antibiotics. The blood samples (pretransfusion and 
posttransfusion samples taken at room temperature) were 
referred to the reference laboratory for investigation. The Hb 
level the next day was 9.6 g/dL, the hemoglobinuria subsided 
quickly, and the bilirubin dropped to 44 μmol/L. There were 
no long-term clinically adverse sequelae, and the child was 
discharged from the hospital the following day with a Hb level 
of 9.2 g/dL.
A culture from the blood units showed no growth. The 
patient’s mycoplasma screening and Paul-Bunnell test for 
glandular fever were negative. 
Materials and Methods
IATs were carried out using gel column agglutination 
(DiaMed Micro-ID System, BioRad Laboratories, Switzerland) 
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at the reference and hospital laboratories. Direct saline 
agglutination test and titration studies were carried out by 
standard tube methods, with the reactants warmed to the 
desired incubation temperature before mixing.
In view of the DAT findings (see Results), the hospital was 
asked to provide  more warm-separated serum from whole 
blood, kept strictly at 37°C, to investigate for indirect Donath-
Landsteiner test, using the method previously described.3
Results
Both pretransfusion and posttransfusion samples were 
examined macroscopically after centrifugation. The color of 
the supernatant plasma from the pretransfusion sample was 
normal (straw colored), whereas that from the posttransfusion 
sample was dirty brown.
Initial serologic results at the reference laboratory for 
both pretransfusion and posttransfusion samples showed the 
patient to be group AB, Rh phenotype DCcEe, and K+, with a 
positive DAT with anti-IgG (1+), anti-IgA (1+), anti-IgM (3+), 
anti-C3c (1+), and anti-C3d (3+). The reverse ABO grouping 
results of the plasma was consistent with group O. None of 
these results were reliable, however, as positive (1+) reactions 
were seen in all the columns containing an inert control. This 
suggested the presence of a cold-reactive antibody.
These results were discrepant with those found at the 
hospital. Although tests there were also carried out by column 
agglutination technology, the samples tested at the reference 
laboratory had been stored at 4°C, whereas those at the 
hospital had been tested without cooling beyond laboratory 
temperature. This allowed for more of the autoantibody to 
be adsorbed onto the RBC surface, thus giving false-positive 
results.
After washing of the RBCs with phosphate-buffered 
saline (PBS), warmed to 37°C, the tests were repeated, and 
the results showed the samples to be group A, probable Rh 
genotype R1R1, K–. The reverse grouping, also incubated at 
37°C, showed the expected negative reaction with A1 RBCs 
and the expected positive reaction with group B RBCs. The 
DAT was positive (3+) with anti-C3d only.
No RBC alloantibodies were detected by the IAT at 37°C 
both in the pretransfusion and posttransfusion samples. 
Repeat crossmatches by the IAT using pretransfusion plasma 
samples and RBCs from the two transfused units were 
compatible.
As the initial tests suggested the presence of a cold-
reactive antibody, titration studies at different temperatures 
were undertaken by saline direct agglutination. Testing was 
performed using the plasma from the pretransfusion samples, 
after warming of the patient’s RBCs to ensure that optimal 
amounts of the autoantibody were eluted back into the plasma, 
as shown in Table 1.
The results indicate the presence of a low-titer, high 
thermal amplitude (reacting at 30°C) cold-reactive antibody 
with anti-I specificity. See Table 1. Reactions with papain-
treated RBCs (not shown) were positive, thus ruling out a 
specificity of anti-Pr. The indirect Donath-Landsteiner test was 
negative, which ruled out anti-P associated with paroxysmal 
cold hemoglobinuria.
Discussion
In general, naturally occurring cold-reactive autoanti-
bodies have a low titer (<64) at 4°C, and have a thermal 
amplitude of less than 20°C.1 The most common cold 
autoagglutinins are directed against the I blood group system.4
Table 1. Specificity and thermal amplitude of cold antibody*
Plasma dilutions
Temperature Cells Neat 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512
4°C Group O adult cells (H+I+) 5+ 5+ 5+ 5+ 3+ 3+ 3+ 2+ 1+ 0
Group A1 adult cells (H–I+) 5+ 5+ 5+ 5+ 3+ 3+ 3+ 2+ 1+ 0
Group O ii adult cells (H+I–) 5+ 5+ 5+ 5+ 4+ 3+ 3+ 2+ 1+ 0
23°C Group O adult cells (H+I+) 5+ 4+ 3+ 2+ 1+ 0 0 0 0 0
Group A1 adult cells (H–I+) 5+ 4+ 3+ 2+ 1+ 0 0 0 0 0
Group O ii adult cells (H+I–) 4+ 3+ 1+ 0 0 0 0 0 0 0
30°C Group O adult cells (H+I+) 1+ 0 0 0 0 0 0 0 0 0
Group A1 adult cells (H–I+) 1+ 0 0 0 0 0 0 0 0 0
Group O ii adult cells (H+I–) 0 0 0 0 0 0 0 0 0 0
*Using different red cell phenotypes, plasma dilutions were tested by direct saline agglutination method to identify the specificity and thermal amplitude of the 
cold antibody.
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Acute HTR caused by autoanti-I
We describe a young child who experienced an AHTR 
caused by an unusual cold-reactive autoantibody. In our 
case, the anti-I IgM cold antibody was detected at 4°C (titer 
256), and the antibody reacted at 30°C. In general, anti-I is 
commonly found in patients with CHD, and the autoantibody 
titer is typically much higher (>1000) at 4°C.2 This was 
not a case of CHD, as there was no laboratory evidence of 
autohemolysis before the transfusion. Also the reaction was 
transient in nature.
Although both units were transfused immediately upon 
removal from the refrigerator, it was during transfusion of the 
second unit that the AHTR occurred. It is conjectured that the 
first unit lowered the peripheral body temperature, and the 
second unit further reduced it to a level at which the autoanti-I 
caused the AHTR.
Cases of autoanti-IH causing AHTR have been well 
described,5,6 but to our knowledge, there was only one 
reported case of autoanti-I with a wide thermal range causing 
intravascular hemolysis.7 In our case, autoanti-I reacted at 
30°C, and this lends weight to the importance of knowing the 
thermal range of the antibody, rather than the specificity or 
titer.
British Committee for Standards in Haematology 
(BCSH) guidelines for the administration of blood and blood 
components stated that “the transfusion of blood and blood 
components should begin as soon as possible after delivery to 
the ward or operating theatre.”8 There is no clear guidance or 
clarification for the administration of RBCs in neonates and 
children.9 Fatal hypothermic reactions have been reported 
after receiving blood transfused immediately upon removal 
from a blood refrigerator.10
We report a rare, unusual case of AHTR caused by 
autoanti-I; this case highlights the potential hazard of 
transfusing units of blood immediately upon removal from 
the blood refrigerator, especially into neonates and children of 
small stature.
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